NCT01374165View on ClinicalTrials.gov

Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Sickle Cell Disease
Trial Locations (1)

Unknown

Rambam Health Care Campus, Haifa

Sponsors
All Listed Sponsors
lead

Prolong Pharmaceuticals

INDUSTRY